研究人员警告称，社交媒体可能误导健康人群接受阿尔茨海默病血液检测，导致人们对可能永远不会引发痴呆症的生物标志物产生严重焦虑。1
包括p-tau217和p-tau181在内的血液生物标志物检测能够检测与阿尔茨海默病相关的脑部生物学变化迹象。1然而，单独使用这些筛查可能会使人们错误地认为他们必然会患上痴呆症。1
社交媒体上关于这类检测的传播正在加剧此类问题，导致健康人群产生不必要的心理压力。1
Researchers have cautioned that social media is promoting inappropriate use of Alzheimer's disease blood tests among healthy individuals, potentially triggering unwarranted anxiety about biomarkers that may never lead to dementia 1. Blood-based biomarker tests, including p-tau217 and p-tau181, can detect signs of brain biological changes associated with Alzheimer's disease 1. However, when these screening tests are used in isolation, they risk misleading people into believing they will inevitably develop dementia 1.
The concern centers on how information about these tests spreads through social media channels, reaching people who may not require clinical evaluation 1. While the biomarkers themselves serve a legitimate diagnostic purpose in medical settings, their popularization through social media has created a gap between their intended use and public perception, causing healthy individuals to experience unnecessary anxiety about biomarkers that may never lead to symptomatic disease 1.
评论
还没有评论，欢迎留下第一条。